P-Cymene

P-Cymene

SCHEMBL932632

CC=O.Cc1ccc(C(C)C)cc1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 3/20 0.56
ACHE P22303 4/20 0.44
BCHE P06276 1/20 0.44
CYP2A6 P11509 1/20 0.44
CHRNA7 P36544 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPK1 P28482 1/20 0.41
CNR2 P34972 1/20 0.40
STAT3 P40763 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
SCN5A Q14524 1/20 0.40
SCN2A Q99250 1/20 0.40
ALOX5 P09917 1/20 0.39
MGLL Q99685 1/20 0.39
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
LMNA P02545 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
P-Cymene SCHEMBL29129733 0.88 TYR (0.54) TYRACHEBCHECYP2A6CHRNA7
P-Cymene SCHEMBL1697748 0.87 ACHE (0.53) TYRACHEBCHECHRNA7CNR2
P-Cymene SCHEMBL1143 0.87 ACHE (0.53) TYRACHEBCHECHRNA7CNR2
P-Cymene SCHEMBL11358150 0.85 TYR (0.44) TYRACHEBCHECHRNA7KDM4E
P-Cymene SCHEMBL27719261 0.84 TYR (0.50) TYRACHEBCHECYP2A6CHRNA7
P-Cymene SCHEMBL31300110 0.84 ACHE (0.50) TYRACHEBCHECHRNA7CNR2
P-Cymene SCHEMBL31606590 0.84 ACHE (0.50) TYRACHEBCHECHRNA7CNR2
P-Cymene SCHEMBL30953569 0.84 ACHE (0.50) TYRACHEBCHECHRNA7CNR2
P-Cymene SCHEMBL13735610 0.84 ACHE (0.50) TYRACHEBCHECHRNA7CNR2
P-Cymene SCHEMBL3684076 0.84 ACHE (0.50) TYRACHEBCHECHRNA7CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2809761-B1 COMBINATION OF 1-AZA-3,7-DIOXABICYCLO[3.3.0]OCTANE COMPOUNDS AND SILICIC ACID ESTER AND USE AS FRAGRANCE PRECURSOR HENKEL AG & CO KGAA (DE) 2017-02-08 EP claimed
WO-2021083642-A1 USE OF SURFACTANTS FROM RENEWABLE RAW MATERIALS HENKEL AG & CO. KGAA (DE) 2021-05-06 WO disclosed
US-20170027823-A1 CAPSULES WITH A HIGH ACTIVE INGREDIENT CONTENT SYMRISE AG (DE) 2017-02-02 US disclosed
EP-3102179-A1 LONG LASTING FRESHENING COMPOSITIONS The Procter & Gamble Company (US) 2016-12-14 EP disclosed
WO-2015119813-A1 LONG LASTING FRESHENING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2015-08-13 WO disclosed
EP-2490663-A2 SILICONE COMPOSITIONS COMPRISING A SWOLLEN SILICONE GEL Dow Corning Corporation (US) 2012-08-29 EP disclosed
EP-2451928-A1 A PROCESS FOR PREPARING A PERFUME PARTICLE The Procter & Gamble Company (US) 2012-05-16 EP disclosed
WO-2011049896-A2 SILICONE COMPOSITIONS COMPRISING A SWOLLEN SILICONE GEL DOW CORNING CORPORATION (US) 2011-04-28 WO disclosed
WO-2011005816-A1 A PROCESS FOR PREPARING A PERFUME PARTICLE THE PROCTER & GAMBLE COMPANY (US) 2011-01-13 WO disclosed
EP-1240304-A1 PERFUME COMPOSITIONS WITH ENHANCED VISCOSITY AND PROCESS FOR THEIR PREPARATION THE PROCTER & GAMBLE COMPANY (US) 2002-09-18 EP disclosed
WO-2001046373-A1 PERFUME COMPOSITIONS WITH ENHANCED VISCOSITY AND PROCESS FOR THEIR PREPARATION THE PROCTER & GAMBLE COMPANY (US) 2001-06-28 WO disclosed
EP-1034202-A1 CO-POLYMERIC COMPOUNDS COMPRISING ONE OR MORE ACTIVE ALDEHYDE MONOMERIC UNIT THE PROCTER & GAMBLE COMPANY (US) 2000-09-13 EP disclosed
EP-1019444-A1 GLYOXYLIC COMPOUND COMPRISING ONE OR MORE ACTIVE INGREDIENT THE PROCTER & GAMBLE COMPANY (US) 2000-07-19 EP disclosed
WO-1999016803-A1 CO-POLYMERIC COMPOUNDS COMPRISING ONE OR MORE ACTIVE ALDEHYDE MONOMERIC UNIT THE PROCTER & GAMBLE COMPANY (US) 1999-04-08 WO disclosed
WO-1999016802-A1 COPOLYMERIC COMPOUNDS COMPRISING ONE OR MORE ACTIVE ALDEHYDE MONOMERIC UNIT THE PROCTER & GAMBLE COMPANY (US) 1999-04-08 WO disclosed
WO-1999016804-A1 GLYOXYLIC COMPOUND COMPRISING ONE OR MORE ACTIVE INGREDIENT THE PROCTER & GAMBLE COMPANY (US) 1999-04-08 WO disclosed
WO-1999016801-A1 GLYOXYLIC COMPOUND COMPRISING ONE OR MORE ACTIVE INGREDIENT THE PROCTER & GAMBLE COMPANY (US) 1999-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170027823-A1 CAPSULES WITH A HIGH ACTIVE INGREDIENT CONTENT TYR, MKI67, GLA TYR 1/4885ACHE 117/4885BCHE 1215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.